Vanguard Group »

Galectin Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.8M 2.1M 2.26
2024-03-31 $4.7M 2.0M 2.39
2023-12-31 $3.2M 1.9M 1.66
2023-09-30 $3.7M 1.9M 1.92
2023-06-30 $2.8M 1.9M 1.44
2023-03-31 $4.1M 1.9M 2.10
2022-12-31 $2.2M 1.9M 1.13
2022-06-30 $2.5M 1.9M 1.31
2022-03-31 $3.1M 1.9M 1.61
2021-09-30 $7.6M 2.0M 3.88
2021-06-30 $6.3M 2.0M 3.24
2021-03-31 $4.2M 1.9M 2.17
2020-12-31 $4.2M 1.9M 2.24
2020-09-30 $4.9M 1.8M 2.67
2020-06-30 $5.7M 1.9M 3.06
2020-03-31 $3.6M 1.8M 1.96
2019-12-31 $5.3M 1.8M 2.86
2019-09-30 $6.7M 1.8M 3.67
2019-03-31 $8.3M 1.6M 5.15
2018-12-31 $4.9M 1.4M 3.44
2018-09-30 $8.5M 1.4M 5.93
2018-06-30 $7.7M 1.2M 6.40
2018-03-31 $5.6M 1.2M 4.80
2017-12-31 $3.1M 915k 3.37
2017-09-30 $1.8M 851k 2.11
2017-06-30 $2.1M 872k 2.42
2017-03-31 $1.7M 737k 2.32
2016-12-31 $501k 527k 0.95
2016-09-30 $684k 590k 1.16
2016-06-30 $910k 607k 1.50
2015-12-31 $981k 602k 1.63
2015-09-30 $1.4M 595k 2.36
2015-06-30 $1.6M 580k 2.75
2015-03-31 $2.0M 610k 3.35
2014-12-31 $2.1M 608k 3.46
2014-09-30 $3.0M 597k 5.03
2014-06-30 $6.9M 501k 13.83
2014-03-31 $6.9M 442k 15.55
2013-12-31 $2.5M 307k 8.08
2013-09-30 $1.6M 161k 9.97
2013-06-30 $372k 88k 4.25
2013-03-31 $55k 15k 3.59